Japanese multicenter study of short- and long-term efficacy and safety of itraconazole in the treatment of chronic necrotizing pulmonary aspergillosis - Japanese multicenter study of itraconazole for chronic necrotizing pulmonary aspergillosis

Department of Clinical infectious Diseases, School of Medicine, Showa University0 个研究点目标入组 100 人开始时间: 2009年2月23日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Pregnant or potentially pregnant women, or lactating women 2) Patients with any underlying diseases considered to have a significant impact on the course of treatment in this clinical study such as progressive cancer, serious heart failure, or serious respiratory failure 3) Patients with a stable lesion restricted to one area of the lung and considered a candidate for surgical resection 4) Patients receiving drugs contraindicated with itraconazole 5) Patients with history of hypersensitivity to itraconazole 6) Presence or history of serious liver disease 7) Patients with severe renal impairment (creatinine clearance < 30 mL/min) 8) Patients for whom inclusion in this clinical study is considered potentially disadvantageous 9) Patients who had been previously included in this study

发起方

Department of Clinical infectious Diseases, School of Medicine, Showa University